Related references
Note: Only part of the references are listed.ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Arnaud Scherpereel et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Biomarkers for malignant pleural mesothelioma: a meta-analysis
Christina N. Gillezeau et al.
CARCINOGENESIS (2019)
MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
Kimberly A. Birnie et al.
DISEASE MARKERS (2019)
Suggestions for designing studies investigating diagnostic accuracy of biomarkers
Man Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Clinical evaluation of circulating miR-548a-3p and-20a expression in malignant pleural mesothelioma patients
Marwa Matboli et al.
BIOMARKERS IN MEDICINE (2018)
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
Hedy L. Kindler et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
Ian Woolhouse et al.
THORAX (2018)
Clinical diagnosis of malignant pleural mesothelioma
Andrea Bianco et al.
JOURNAL OF THORACIC DISEASE (2018)
Investigating unilateral pleural effusions: the role of cytology
David T. Arnold et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease
Tommaso Cavalleri et al.
PLOS ONE (2017)
MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study
Paola Mozzoni et al.
DISEASE MARKERS (2017)
The biology, function and clinical implications of exosomes in lung cancer
Li Zhou et al.
CANCER LETTERS (2017)
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology
Rocco Cappellesso et al.
CANCER CYTOPATHOLOGY (2017)
Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma
Daniel G. Weber et al.
DISEASE MARKERS (2017)
Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology
Rocco Cappellesso et al.
CANCER CYTOPATHOLOGY (2016)
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers
Ilaria Bononi et al.
ONCOTARGET (2016)
Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis
Ran Ren et al.
ONCOTARGET (2016)
Circulating biomarker for malignant pleural mesothelioma diagnosis: pay attention to study design
Zhi-De Hu
JOURNAL OF THORACIC DISEASE (2016)
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database
Robert Ryan Meyerhoff et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma
Lory Santarelli et al.
LUNG CANCER (2015)
Efficacy and Safety of Diagnostic Thoracoscopy in Undiagnosed Pleural Effusions
Xiao-Juan Wang et al.
RESPIRATION (2015)
MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion
Guntulu Ak et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Etiology of Pleural Effusions: Analysis of More than 3,000 Consecutive Thoracenteses
Jose M. Porcel et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2014)
Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: A systematic review and meta-analysis
Zhi-De Hu et al.
CLINICA CHIMICA ACTA (2014)
Diagnostic Potential of miR-126, miR-143, miR-145, and miR-652 in Malignant Pleural Mesothelioma
Morten Andersen et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
Daniel G. Weber et al.
PLOS ONE (2014)
Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis
Ai Cui et al.
BMJ OPEN (2014)
Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients
Marco Tomasetti et al.
CLINICAL BIOCHEMISTRY (2012)
Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis
Kevin Hollevoet et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Increased Circulating miR-625-3p A Potential Biomarker for Patients With Malignant Pleural Mesothelioma
Michaela B. Kirschner et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma - A Pilot Study
Daniel G. Weber et al.
PLOS ONE (2012)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
Lory Santarelli et al.
PLOS ONE (2011)
MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic Implications
Sara Busacca et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases
Yi Zhang et al.
CLINICAL CHEMISTRY (2010)
Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction
Taichi Adachi et al.
CLINICAL CHEMISTRY (2010)
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
Gretchen V. Gee et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural Mesothelioma
Hila Benjamin et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
MicroRNAs: Novel Biomarkers for Human Cancer
Claudine L. Bartels et al.
CLINICAL CHEMISTRY (2009)
CDKN2A, NF2, and JUN Are Dysregulated Among Other Genes by miRNAs in Malignant Mesothelioma-A miRNA Microarray Analysis
Mohamed Guled et al.
GENES CHROMOSOMES & CANCER (2009)
Malignant Pleural Mesothelioma
Anne S. Tsao et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Share Paper
